{
    "Trade/Device Name(s)": [
        "BBL Sensi-Disc Antimicrobial Susceptibility Test Disks, Telithromycin 15\u03bcg",
        "Telithromycin 15\u03bcg BBL Sensi-Disc Antimicrobial Susceptibility Test Disks"
    ],
    "Submitter Information": "Becton Dickinson and Company",
    "510(k) Number": "K052876",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JTN"
    ],
    "Summary Letter Date": "November 14, 2005",
    "Summary Letter Received Date": "October 12, 2005",
    "Submission Date": "October 11, 2005",
    "Regulation Number(s)": [
        "21 CFR 866.1620"
    ],
    "Regulation Name(s)": [
        "Antimicrobial Susceptibility Test Disc"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Telithromycin"
    ],
    "Specimen Type(s)": [
        "Pure bacterial culture"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Agar diffusion susceptibility test",
        "Paper disk diffusion"
    ],
    "Methodologies": [
        "Agar diffusion",
        "Zone diameter measurement",
        "Categorical interpretation (S/I/R)"
    ],
    "Submission Type(s)": [
        "Disk",
        "Susceptibility test"
    ],
    "Document Summary": "FDA 510(k) summary for BBL Sensi-Disc Antimicrobial Susceptibility Test Disks impregnated with Telithromycin 15\u03bcg for in vitro determination of bacterial susceptibility.",
    "Indications for Use Summary": "Used for in vitro agar diffusion testing to determine bacterial susceptibility to telithromycin; shown active in vitro against Staphylococcus aureus (methicillin and erythromycin susceptible isolates), Streptococcus pneumoniae (including multidrug resistant), Haemophilus influenzae, Streptococcus pyogenes (erythromycin susceptible), Streptococci (Lancefield groups C and G), and Viridans group streptococci.",
    "fda_folder": "Microbiology"
}